Changes in Brain &bgr;-Amyloid Deposition and Aquaporin 4 Levels in Response to Altered Agrin Expression in Mice

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  2011-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/NEN.0b013e31823b0b12PMID 22082664PMCID PMC3223604
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of agrin on the formation of orthogonal arrays of particles in cultured astrocytes from wild-type and agrin-null mice.

  2011cited by this paper
• Evidence for a role of dystroglycan regulating the membrane architecture of astroglial endfeet

  2011cited by this paper
• Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

  2010cited by this paper
• Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease

  2010influential reference
• Agrin, Aquaporin-4, and Astrocyte Polarity as an Important Feature of the Blood-Brain Barrier

  2009cited by this paper
• Identification and function of agrin expressed in rat brain microvessels.

  2009cited by this paper
• Amyloid (cid:1) -Protein Toxicity and the Pathogenesis of Alzheimer Disease

  2009cited by this paper
• Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship

  2009cited by this paper
• Agrin defines polarized distribution of orthogonal arrays of particles in astrocytes

  2009cited by this paper
• Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease.

  2009cited by this paper
• Amyloid beta induces cellular relocalization and production of agrin and glypican-1.

  2009cited by this paper
• Mild cognitive impairment and alzheimer disease: patterns of altered cerebral blood flow at MR imaging.

  2009cited by this paper
• Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease

  2009cited by this paper
• Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

  2008cited by this paper
• Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.

  2008cited by this paper
• The blood-brain barrier in health and chronic neurodegenerative disorders.

  2008cited by this paper
• Aβ Oligomers – a decade of discovery

  2007cited by this paper
• Defects in eye development in transgenic mice overexpressing the heparan sulfate proteoglycan agrin.

  2007cited by this paper
• Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity.

  2007cited by this paper
• Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype

  2007cited by this paper
• Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous System

  2007cited by this paper
• SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease

  2007cited by this paper
• Effects of agrin on the expression and distribution of the water channel protein aquaporin‐4 and volume regulation in cultured astrocytes

  2007cited by this paper
• RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

  2006cited by this paper
• Clearance of Alzheimer's Aβ Peptide

  2004cited by this paper
• Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

  2004cited by this paper
• Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology—a pilot study

  2004cited by this paper
• Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase.

  2004influential reference
• Redistribution of aquaporin-4 in human glioblastoma correlates with loss of agrin immunoreactivity from brain capillary basal laminae

  2004cited by this paper
• Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase

  2004cited by this paper
• Early-onset and Robust Cerebral Microvascular Accumulation of Amyloid β-Protein in Transgenic Mice Expressing Low Levels of a Vasculotropic Dutch/Iowa Mutant Form of Amyloid β-Protein Precursor*

  2004cited by this paper
• Erratum to “Gender differences in the amount and deposition of amyloidβ in APPswe and PS1 double transgenic mice” [Neurobiol. Dis. 14 (2003) 318–327]

  2004cited by this paper
• Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes.

  2004cited by this paper
• Clearance of Alzheimer's Aβ PeptideThe Many Roads to Perdition

  2004cited by this paper
• Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit

  2003cited by this paper
• Corrigendum to “Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease” [J. Neurol. Sci. 203–204 (2002) 183–187]

  2003cited by this paper
• Expression of mouse agrin in normal, denervated and dystrophic muscle.

  2003cited by this paper
• Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice.

  2003cited by this paper
• Two Types of Sporadic Cerebral Amyloid Angiopathy

  2002influential reference
• Rapid detection of protein aggregates in the brains of Alzheimer patients and transgenic mouse models of amyloidosis.

  2002cited by this paper
• Mapping sites responsible for interactions of agrin with neurons

  2002cited by this paper
• Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease.

  2002cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• An alternative amino-terminus expressed in the central nervous system converts agrin to a type II transmembrane protein.

  2001cited by this paper
• Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention.

  2001cited by this paper
• Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo.

  2001cited by this paper
• Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice.

  2001cited by this paper
• Agrin Binds to β-Amyloid (Aβ), Accelerates Aβ Fibril Formation, and Is Localized to Aβ Deposits in Alzheimer's Disease Brain

  2000cited by this paper
• Agrin isoforms with distinct amino termini: differential expression, localization, and function.

  2000cited by this paper
• Agrin and microvascular damage in Alzheimer's disease.

  2000cited by this paper
• Agrin Isoforms with Distinct Amino Termini

  2000cited by this paper
• Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain.

  2000cited by this paper
• Agrin in Alzheimer's disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma.

  1999cited by this paper
• Development of the vertebrate neuromuscular junction.

  1999cited by this paper
• The Sulfate Moieties of Glycosaminoglycans Are Critical for the Enhancement of β‐Amyloid Protein Fibril Formation

  1999cited by this paper
• Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.

  1999cited by this paper
• A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1

  1998cited by this paper
• Differential Expression of Agrin in Renal Basement Membranes As Revealed by Domain-specific Antibodies*

  1998cited by this paper
• Cre–mediated chromosome loss in mice

  1997cited by this paper
• Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier.

  1997cited by this paper
• Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.

  1997cited by this paper
• Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability

  1997cited by this paper
• Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease

  1996cited by this paper
• A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene

  1995cited by this paper
• The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease.

  1988cited by this paper

• Agrin at the Crossroads of Aging: A Pleiotropic Regulator in Age-Related Diseases.

  2026cites this paper
• Amyloid neuropathy, tauopathy, decreased cholinergic and dopaminergic neurons, long-term memory and motor deficits, and sleep disturbance in motopsin deficient mice.

  2025cites this paper
• Structural changes in cerebral microvasculature induced by ferroptosis contribute to blood–brain barrier disruption in Alzheimer's disease: an autopsy study

  2025cites this paper
• Laminins and the Blood-Brain Barrier.

  2025cites this paper
• Biomimetic strategies for the deputization of proteoglycan functions

  2024cites this paper
• Update on the intriguing roles of AQP4 expression and redistribution in the progression and treatment of glioma

  2024cites this paper
• Single-cell transcriptome atlas in C57BL/6 mice encodes morphological phenotypes in the aging kidneys

  2024cites this paper
• Extracellular matrix proteins in construction and function of in vitro blood-brain barrier models

  2023cites this paper
• GABA promotes interstitial fluid clearance in an AQP4‐dependent manner by activating the GABAAR

  2023cites this paper
• Heparan Sulfate in Alzheimer's Disease: Aberrant expression and functions in molecular pathways related to amyloid-β metabolism.

  2023cites this paper
• Urinary protein biomarkers based on LC–MS/MS analysis to discriminate vascular dementia from Alzheimer’s disease in Han Chinese population

  2023cites this paper
• Signaling Mechanisms and Pharmacological Modulators Governing Diverse Aquaporin Functions in Human Health and Disease

  2022cites this paper
• Analysis of Cerebral Small Vessel Changes in AD Model Mice

  2022cites this paper
• The mechanisms underlying the actions of Xuefu Zhuyu decoction pretreatment against neurological deficits after ischemic stroke in mice: The mediation of glymphatic function by aquaporin-4 and its anchoring proteins

  2022cites this paper
• MRI-Visible Perivascular Spaces and Risk of Incident Dementia

  2022influential citation
• Blood-Brain Barrier Alterations and Edema Formation in Different Brain Mass Lesions

  2022cites this paper
• The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates

  2022cites this paper
• The amyloid plaque proteome in early onset Alzheimer’s disease and Down syndrome

  2022cites this paper
• Abeta Peptides Disrupt the Barrier Integrity and Glucose Metabolism of Human Induced Pluripotent Stem Cell-Derived Brain Microvascular Endothelial Cells.

  2022cites this paper
• Extracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology

  2021cites this paper
• Integration of System Biology Tools to Investigate Huperzine A as an Anti-Alzheimer Agent

  2021cites this paper
• Basal lamina changes in neurodegenerative disorders

  2021influential citation
• Emerging roles for dynamic aquaporin-4 subcellular relocalization in CNS water homeostasis

  2021cites this paper
• Identification of Key Pathways and Genes in Dementia via Integrated Bioinformatics Analysis

  2021cites this paper
• HIV-1 and Amyloid Beta Remodel Proteome of Brain Endothelial Extracellular Vesicles

  2020cites this paper
• Basement Membrane Changes in Ischemic Stroke

  2020cites this paper
• A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance

  2020cites this paper
• Investigating Causal Relations Between Risk Tolerance, Risky Behaviors, and Alzheimer’s Disease: A Bidirectional Two-Sample Mendelian Randomization Study

  2020cites this paper
• A Comprehensive Analysis of Unique and Recurrent Copy Number Variations in Alzheimer's Disease and its Related Disorders.

  2020cites this paper
• Deciphering molecular interactions of AQP4 at the gliovascular interface in brain

  2019cites this paper
• Transcriptome Changes in the Alzheimer’s Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes

  2019cites this paper
• Chronic stress impairs the aquaporin-4-mediated glymphatic transport through glucocorticoid signaling

  2019cites this paper
• Distinctive peri-luminal presence of agrin in murine and human carotid atherosclerotic plaques.

  2018cites this paper
• Pla2g6 Deficiency in Zebrafish Leads to Dopaminergic Cell Death, Axonal Degeneration, Increased β-Synuclein Expression, and Defects in Brain Functions and Pathways

  2018cites this paper
• Reactive Astrocytes as Drug Target in Alzheimer's Disease

  2018cites this paper
• Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines

  2018cites this paper
• Functional Roles of the Interaction of APP and Lipoprotein Receptors

  2017cites this paper
• Die Verankerung von Aquaporin-4 durch den Dystrophin-assoziierten Proteinkomplex im Ductus cochlearis des Menschen und der Ratte

  2017cites this paper
• The vascular basement membrane in the healthy and pathological brain

  2017cites this paper
• Human and mouse cortical astrocytes differ in aquaporin‐4 polarization toward microvessels

  2017cites this paper
• A Novel Egr-1-Agrin Pathway and Potential Implications for Regulation of Synaptic Physiology and Homeostasis at the Neuromuscular Junction

  2017cites this paper
• Synthesis and deposition of basement membrane proteins by primary brain capillary endothelial cells in a murine model of the blood–brain barrier

  2017cites this paper
• Blood–Brain Barrier and Edema in Brain Tumors

  2017cites this paper
• The potential roles of aquaporin 4 in malignant gliomas

  2017cites this paper
• Neuronal heparan sulfates promote amyloid pathology by modulating brain amyloid-β clearance and aggregation in Alzheimer’s disease

  2016cites this paper
• Factors controlling permeability of the blood–brain barrier

  2015cites this paper
• Reduced CSF Water Influx in Alzheimer’s Disease Supporting the β-Amyloid Clearance Hypothesis

  2015cites this paper
• Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?

  2015cites this paper
• Postnatal development of the molecular complex underlying astrocyte polarization

  2014cites this paper
• The heparan sulfate proteoglycan agrin contributes to barrier properties of mouse brain endothelial cells by stabilizing adherens junctions

  2014cites this paper
• In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies

  2014cites this paper
• Physiological roles of aquaporin-4 in brain.

  2013cites this paper
• Evidence that pericytes regulate aquaporin-4 polarization in mouse cortical astrocytes

  2013cites this paper
• Amyloid beta accumulation in HIV‐1‐infected brain: The role of the blood brain barrier

  2013cites this paper
• Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease

  2013cites this paper
• Exploration of neuromuscular plasticity: an examination of acetylcholine receptor and skeletal muscle fiber adaptations

  2012influential citation
• The disturbed blood-brain barrier in human glioblastoma.

  2012cites this paper
• The role of Aquaporin 4 in Astrocytes is a Target for Therapy in Alzheimer’s Disease

  year unknowncites this paper
• Drug Design: Influence of Heterocyclic Structure as Bioisosteres

  year unknowncites this paper